Abstract: The present application relates to a psicose-6-phosphate phosphatase comprising motif A and motif B, a composition for producing D-psicose comprising the enzyme, and a method for producing D-psicose using the enzyme.

Abstract: Provided are a piperidine derivative compound, a hydrate thereof, a solvate thereof, or a pharmaceutically acceptable salt thereof; and a pharmaceutical composition for the prevention or treatment of diseases related to autotaxin activity, comprising same as an active ingredient, in which the piperidine derivative compound exhibits excellent inhibitory activity against autotaxin, and thus can be effectively used in the treatment and prevention of diseases related to autotaxin inhibition, such as fibrotic diseases, inflammatory diseases, autoimmune diseases, respiratory diseases, cardiovascular diseases, metabolic diseases, cancer and cancer metastasis, ocular diseases, cholestatic form and other forms of chronic pruritus, and acute or chronic organ transplant rejection.

Abstract: Provided is a heat pump system including a compressor for compressing a refrigerant the heat pump system including: an input interface configured to receive an input of an authentication code; a display configured to display the authentication code input through the input interface; and a controller to control an operation of the heat pump system according to whether a control program to control the operation is to be activated based on the authentication code input through the input interface.

Abstract: Proposed is a process for collecting and removing microplastics in wastewater. The process includes coagulating microplastics in wastewater and adding an enzyme to the coagulated microplastics. Also, a method for collecting and removing microplastics is provided, the process comprising: pulverizing polyethylene terephthalate (PET) bottles into microplastics; dispersing the microplastics into a water system; coagulating the microplastics to produce coagulated microplastics; and adding an enzyme to the coagulated microplastics whereby the coagulated microplastics are decomposed by the enzyme into their monomer constituents. According to this process and method, the microplastics in wastewater can be removed with high efficiency.

Abstract: Proposed is an electro-coagulation apparatus. The electro-coagulation apparatus includes a reactor having an internal space defined by a top surface, a bottom surface, and a side surface of the reactor; a plurality of electrode plates disposed spaced apart from each other inside the internal space of the reactor, and a pair of first conduits respectively connected to a front end and a rear end of the reactor. Furthermore, a cross-sectional area of the reactor is smaller than a cross-sectional area of each of the first conduits.

Abstract: A method for treating wastewater is proposed, the method including providing wastewater containing microplastics, forming aggregates in the wastewater using iron ions, separating supernatant and the aggregates from the wastewater, subjecting the aggregates to aging, and subjecting the aggregates to heat treatment, and a system that can implement the method is also proposed.

Abstract: According to embodiments of the present disclosure, there is provided a process of removing aluminum waste from wastewater. The process includes (a) supplying, as a feed, wastewater containing aluminum; (b) separating the wastewater into a liquid component and a sludge component containing the aluminum; (c) reacting the sludge component with sulfuric acid to produce aluminum sulfate; (d) mixing the aluminum sulfate with alcohol to produce aluminum sulfate hydrate; and (e) adding the aluminum sulfate hydrate produced in step (d) to the wastewater of step (a) and/or to another wastewater. The process can cost-effectively remove waste from wastewater and reduce the content of waste contained in the effluent from being discharged.

Abstract: Provided are a piperidine derivative compound, a hydrate thereof, a solvate thereof, or a pharmaceutically acceptable salt thereof; and a pharmaceutical composition for the prevention or treatment of diseases related to autotaxin activity, comprising same as an active ingredient, in which the piperidine derivative compound exhibits excellent inhibitory activity against autotaxin, and thus can be effectively used in the treatment and prevention of diseases related to autotaxin inhibition, such as fibrotic diseases, inflammatory diseases, autoimmune diseases, respiratory diseases, cardiovascular diseases, metabolic diseases, cancer and cancer metastasis, ocular diseases, cholestatic form and other forms of chronic pruritus, and acute or chronic organ transplant rejection.

Abstract: Provided are a fructose-4-epimerase variant having tagatose conversion activity, and a method of preparing tagatose using the same.

Abstract: Proposed is a method of monitoring odor-causing substances in flue gas, which comprises: providing a flue gas containing one or more odor-causing substances; introducing the flue gas into an odor removal unit; producing a gas-phase stream; dissolving a portion of the gas-phase stream in a solvent to produce a liquid-phase stream; and measuring an absorbance of the liquid-phase stream to identify the odor-causing substances.

Abstract: The present invention relates to new antibody-drug conjugates (ADCs) targeting ROR1, active metabolites of such ADCs, methods for preparation of such ADCs, uses for such ADCs in treatment and/or prevention of illnesses, and uses for such ADCs in production of drugs for treatment and/or prevention of diseases, more specifically diseases associated with over-expression of ROR1, for example cancer. More specifically, the present invention relates to an antibody-drug conjugate comprising an antibody that binds to ROR1 or an antigen-binding fragment thereof, and a pharmaceutical composition comprising the same.

Abstract: Provided are a composition for producing tagatose, comprising fructose-6-phosphate 4-epimerase, and a method of producing tagatose using the same.

Abstract: Provided are a tagatose-bisphosphate aldolase variant having tagatose conversion activity, and a method of preparing tagatose using the same.

Abstract: The present invention relates to new antibody-drug conjugates (ADCs) targeting ROR1, active metabolites of such ADCs, methods for preparation of such ADCs, uses for such ADCs in treatment and/or prevention of illnesses, and uses for such ADCs in production of drugs for treatment and/or prevention of diseases, more specifically diseases associated with over-expression of ROR1, for example cancer. More specifically, the present invention relates to an antibody-drug conjugate comprising an antibody that binds to ROR1 or an antigen-binding fragment thereof, and a pharmaceutical composition comprising the same.

Abstract: The present invention relates to a method of reducing carbon dioxide and air pollutants, and more particularly to a method of simultaneously reducing emissions of carbon dioxide and air pollutants, in which an off-gas containing carbon dioxide, SOx, and NOx is passed through a sulfur-oxidizing microorganism reactor, thereby converting carbon dioxide present in the off-gas into biomass, SOx into sulfate ions, and NOx into amino-N.

Abstract: The present disclosure relates to a composition for producing tagatose, comprising fructose-6-phosphate-4-epimerase, and a method of producing tagatose using the same.

Abstract: Provided are a hexuronate C4-epimerase variant with improved activity in converting D-fructose by D-tagatose of hexuronate C4-epimerase and a method for production of D-tagatose using them.

Abstract: Provided are a fructose-4-epimerase variant having tagatose conversion activity, and a method of producing tagatose using the same.

Abstract: The present invention relates to a method of reducing carbon dioxide and air pollutants, and more particularly to a method of simultaneously reducing emissions of carbon dioxide and air pollutants, in which an off-gas containing carbon dioxide, SOx, and NOx is passed through a sulfur-oxidizing microorganism reactor, thereby converting carbon dioxide present in the off-gas into biomass, SOx into sulfate ions, and NOx into amino-N.

Abstract: Provided are a composition for producing tagatose, comprising fructose-6-phosphate 4-epimerase, and a method of producing tagatose using the same.